Clinical Context
We think this might be relevant to the clinical guidance for FIGO 2023 Endometrial Cancer Staging.
Clinical Context
We think this might be relevant to the clinical guidance for FIGO 2023 Endometrial Cancer Staging.
Clinical Context
We think this might be relevant to the clinical guidance for FIGO 2023 Endometrial Cancer Staging.
FIGO 2023Endometrial Cancer Molecular & Clinical Staging
2023 Revision Note
The 2023 update integrates molecular classification. For example, a tumor formerly staged as IA but with a p53 abnormal profile might be upstaged to reflect its higher risk.
Stage Assessment
Clinical Strategy
Early stage disease. Management is increasingly guided by molecular classification (e.g., POLEmut vs p53abn).
Verified
Last Review: 2026
Last Comprehensive Review: 2026